Get started
Award

セラノスティクス概念を具現化するための創薬拠点整備を伴う、抗体等標識治療薬(アルファ線)とコンパニオン診断薬の開発

Funding type: research
Funder scheme: 医療研究開発革新基盤創成事業
Investigator: 波多野正
Institution: 日本メジフィジックス株式会社
Funded outputs count: 4
Funder award ID: 17pc0101014h0001
OpenAlex ID: G6206403274
First-in-Human Total-Body PET/CT Imaging Using89Zr-Labeled MUC5AC Antibody in a Patient with Pancreatic Adenocarcinoma
2024 · Harshad R. Kulkarni, Kevin A. Maupin, et al. · Journal of Nuclear Medicine · 3
PDF
Research and Development for Cyclotron Production of 225Ac from 226Ra—The Challenges in a Country Lacking Natural Resources for Medical Applications
2022 · Tatsuya Higashi, Kotaro Nagatsu, et al. · Processes · 28
PDF
Radiation dosimetry and efficacy of an 89Zr/225Ac-labeled humanized anti-MUC5AC antibody
2022 · Norihito Nakata, Nobuya Kobashi, et al. · Nuclear Medicine and Biology · 17
PDF
Cyclotron production of 225Ac from an electroplated 226Ra target
2021 · Kotaro Nagatsu, Hisashi Suzuki, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 59
PDF
Year
Topic